Clinical Trial Update: Study of Copanlisib and Ketogenic Diet [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating copanlisib in combination with a ketogenic diet for follicular lymphoma and endometrial cancer was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Follicular Lymphoma

Drugs mentioned

• Copanlisib (copanlisib)

Snippet

Sponsor: Columbia University | Conditions: Follicular Lymphoma, Endometrial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-03-04